Literature DB >> 21028815

Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis.

Neil Loftus1, Alan Barnes, Simon Ashton, Filippos Michopoulos, Georgios Theodoridis, Ian Wilson, Cheng Ji, Neil Kaplowitz.   

Abstract

Alcoholism is a complex disorder that, in man, appears to be genetically influenced, although the underlying genes and molecular pathways are not completely known. Here, the intragastric alcohol feeding model in rodents was used together with high mass accuracy LC-MS(n) analysis to assess the metabonomic changes in nonpolar metabolite profiles for livers from control and alcohol-treated rats and mice. Ion signals with a peak area variance of less than 30% (based on repeat analysis of a pooled quality control sample analyzed throughout the batch) were submitted to multivariate statistical analysis (using principal components analysis, PCA). PCA revealed robust differences between profiles from control and alcohol-treated animals from both species. The major metabolites seen to differ between control and alcohol-treated animals were identified using high accuracy MS(n) data and verified using external search engines ( http://www.lipidmaps.org ; http://www.hmdb.ca; http://www.genome.jp/kegg/ ) and authentic standards. The main metabolite classes to show major changes in the alcoholic liver-derived samples were fatty acyls, fatty acid ethyl esters, glycerolipids, and phosphatidylethanol homologues. Significant metabolites that were up-regulated by alcohol treatment in both rat and mouse livers included fatty acyls, metabolites such as octadecatrienoic acid and eicosapentaenoic acid, a number of fatty acid ethyl esters such as ethyl arachidonate, ethyl docosahexaenoic acid, ethyl linoleate, and ethyl oleate and phosphatidylethanol (PEth) homologues (predominantly PEth 18:0/18:2 and PEth 16:0/18:2; PEth homologues are currently considered as potential biomarkers for harmful and prolonged alcohol consumption in man). A number of glycerophospholipids resulted in both up-regulation (m/z 903.7436 [M + H](+) corresponding to a triglyceride) and down-regulation (m/z 667.5296 [M + H](+) corresponding to a diglyceride). Metabolite profiles were broadly similar in both mouse and rat models. However, there were a number of significant differences in the alcohol-treated group particularly in the marked down-regulation of retinol and free cholesterol in the mouse compared to the rat. Unique markers for alcohol treatment included ethyl docosahexaenoic acid. Metabolites were identified with high confidence using predominantly negative ion MS(n) data for the fatty acyl components to match to www.lipidmaps.org MS and MS/MS databases; interpreting positive ion data needed to take into account possible adduct ions which may confound the identification of other lipid classes. The observed changes in lipid profiles were consistent with alcohol-induced liver injury in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21028815      PMCID: PMC3033970          DOI: 10.1021/pr100885w

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  19 in total

Review 1.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.

Authors:  J K Nicholson; J C Lindon; E Holmes
Journal:  Xenobiotica       Date:  1999-11       Impact factor: 1.908

Review 2.  Metabolomics--the link between genotypes and phenotypes.

Authors:  Oliver Fiehn
Journal:  Plant Mol Biol       Date:  2002-01       Impact factor: 4.076

Review 3.  Metabonomics: a platform for studying drug toxicity and gene function.

Authors:  Jeremy K Nicholson; John Connelly; John C Lindon; Elaine Holmes
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

4.  Global metabolic profiling procedures for urine using UPLC-MS.

Authors:  Elizabeth J Want; Ian D Wilson; Helen Gika; Georgios Theodoridis; Robert S Plumb; John Shockcor; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-06       Impact factor: 13.491

Review 5.  Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report.

Authors:  H Tsukamoto; K Gaal; S W French
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

6.  An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse.

Authors:  C L Gavaghan; E Holmes; E Lenz; I D Wilson; J K Nicholson
Journal:  FEBS Lett       Date:  2000-11-10       Impact factor: 4.124

7.  Ethyl glucuronide--a marker of alcohol consumption and a relapse marker with clinical and forensic implications.

Authors:  F M Wurst; C Kempter; S Seidl; A Alt
Journal:  Alcohol Alcohol       Date:  1999 Jan-Feb       Impact factor: 2.826

8.  Long-term cannulation model for blood sampling and intragastric infusion in the rat.

Authors:  H Tsukamoto; R D Reidelberger; S W French; C Largman
Journal:  Am J Physiol       Date:  1984-09

Review 9.  ESBRA 1994 Award Lecture. Phosphatidylethanol formation: specific effects of ethanol mediated via phospholipase D.

Authors:  L Gustavsson
Journal:  Alcohol Alcohol       Date:  1995-07       Impact factor: 2.826

10.  Differences in betaine-homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol-fed mice and rats.

Authors:  Masao Shinohara; Cheng Ji; Neil Kaplowitz
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

View more
  24 in total

1.  In silico enzymatic synthesis of a 400,000 compound biochemical database for nontargeted metabolomics.

Authors:  Lochana C Menikarachchi; Dennis W Hill; Mai A Hamdalla; Ion I Mandoiu; David F Grant
Journal:  J Chem Inf Model       Date:  2013-09-12       Impact factor: 4.956

Review 2.  The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver.

Authors:  Robin D Clugston; Madeleine A Gao; William S Blaner
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Evolution of the liver biopsy and its future.

Authors:  Dhanpat Jain; Richard Torres; Romulo Celli; Jeremy Koelmel; Georgia Charkoftaki; Vasilis Vasiliou
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

4.  Investigation of chronic alcohol consumption in rodents via ultra-high-performance liquid chromatography-mass spectrometry based metabolite profiling.

Authors:  Helen G Gika; Cheng Ji; Georgios A Theodoridis; Filippos Michopoulos; Neil Kaplowitz; Ian D Wilson
Journal:  J Chromatogr A       Date:  2012-03-03       Impact factor: 4.759

5.  Global metabolic profiling of animal and human tissues via UPLC-MS.

Authors:  Elizabeth J Want; Perrine Masson; Filippos Michopoulos; Ian D Wilson; Georgios Theodoridis; Robert S Plumb; John Shockcor; Neil Loftus; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2012-12-06       Impact factor: 13.491

Review 6.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

7.  UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.

Authors:  Soumen K Manna; Andrew D Patterson; Qian Yang; Kristopher W Krausz; Jeffrey R Idle; Albert J Fornace; Frank J Gonzalez
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

8.  Altered hepatic retinyl ester concentration and acyl composition in response to alcohol consumption.

Authors:  Robin D Clugston; Hongfeng Jiang; Man Xia Lee; Paul D Berk; Ira J Goldberg; Li-Shin Huang; William S Blaner
Journal:  Biochim Biophys Acta       Date:  2013-04-12

9.  Hepatic lipid profiling of deer mice fed ethanol using ¹H and ³¹P NMR spectroscopy: a dose-dependent subchronic study.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Paul J Boor; G A Shakeel Ansari; Bhupendra S Kaphalia
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-03       Impact factor: 4.219

10.  Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Habtom W Ressom; Jun Feng Xiao; Leepika Tuli; Rency S Varghese; Bin Zhou; Tsung-Heng Tsai; Mohammad R Nezami Ranjbar; Yi Zhao; Jinlian Wang; Cristina Di Poto; Amrita K Cheema; Mahlet G Tadesse; Radoslav Goldman; Kirti Shetty
Journal:  Anal Chim Acta       Date:  2012-07-20       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.